The HIV diagnosis industry is projected to generate $4.13 billion in 2021, rising at a rate of 9.7% from 2021-2030, to capture $9.55 billion revenue in 2030. The rising prevalence of AIDS, led by increasing transfusions, and blood donations fuel the demand for HIV diagnosis.
There are majorly three types of HIV tests: Antigen/antibody tests, antibody tests, and nucleic acid tests (NAT).
Antibody tests detect HIV to identify HIV in a person’s blood or oral fluid. The antibody test scan takes 23 to 90 days for the detection of HIV after exposure. Antibody testing involves blood usage from a vein that can soon detect HIV, after injecting tests with blood from a finger stick or oral fluid.
Antigen tests involve looking for both antigens and HIV antibodies. A person’s immune system produces antibodies when they are exposed to HIV viruses. Antigens are considered foreign substances that affect an individual’s immune system.
NAT involves looking for the actual virus in the blood. This test is usually recommended for people with recent exposure or possible exposure to early HIV symptoms. This test can detect HIV in 10 to 33 days after exposure.
An HIV-infected person produces a p24 antigen to develop antibodies. An antigen/antibody test is usually performed in the lab on vein blood that can detect HIV in 18 to 45 days after exposure. There is quick availability of finger stick antigen/ antibody tests.
Make inquiry before purchase of this report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=hiv-diagnosis-market
Additionally, point-of-care kits and instrument advantages are projected to fuel the industry’s growth.
AIDS virus can be spread through infected blood transfusion, or compromised needles to a healthy individual. The government associations’ participation in educational programs has resulted in growing awareness of worldwide unsafe blood transfusion and blood donations.
The point-of-care kits and instruments are projected to fuel the industry growth in the coming years.
Several associations of WHO including Red Crescent Societies, the American Red Cross, and the International Federation of Red Cross support blood donation programs and are aware of people to safely donate blood and blood components.
The unsterilized needles usage during blood transfusion results in high infection risk, and thus fuels the industry’s growth.
In addition, the rising awareness of increasing blood transfusions and blood donations is projected to result in a growing prevalence of HIV infection, which boost the industry growth.
The emergence of point-of-care instruments and kits for infection detection leads to an increased rate of diagnosis.
The pint-of-care instruments and kits are convenient, affordable, and time-saving, and provide high-confirmatory testing. Moreover, the instruments and kits provide offer easy-to-perform medical tests at the point of care or bedside.
The rising usage of these devices by HIV-infected individuals and cautious people boosts the industry’s growth in the coming future.
Over the last few years, the increasing healthcare expenditure in numerous countries has reduced the AIDS burden, more specifically in low- and middle-income countries.
The rising awareness on blood donations propel requirement for HIV diagnosis.
